Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway
Clinical trial NCT05194124 · COMPLETED
Trial details
- NCT number
- NCT05194124
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2023-10-19
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.